Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer.
Hande SuerSuat ErusEkin E CesurÖmer YavuzOrhan AğcaoğluPınar BulutayTamer T ÖnderSerhan TanjuŞükrü DilegePublished in: Journal of cardiothoracic surgery (2023)
A combination of CK19, EpCAM and CEACAM5 gene expressions in lymph nodes can be used to identify micrometastasis which postoperatively may be used as a tool to predict patients' recurrence and survival.
Keyphrases
- lymph node
- prognostic factors
- end stage renal disease
- neoadjuvant chemotherapy
- sentinel lymph node
- chronic kidney disease
- circulating tumor cells
- genome wide
- ejection fraction
- copy number
- newly diagnosed
- protein kinase
- genome wide identification
- cell adhesion
- free survival
- early stage
- transcription factor
- radiation therapy
- patient reported outcomes
- dna methylation